Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

dc.contributor.authorBonanad, Clara
dc.contributor.authorEsteve Claramunt, Francisca
dc.contributor.authorGarcía Blas, Sergio
dc.contributor.authorAyesta, Ana
dc.contributor.authorDíez Villanueva, Pablo
dc.contributor.authorPérez Rivera, Jose Ángel
dc.contributor.authorFerreiro, José Luis
dc.contributor.authorCánoves, Joaquim
dc.contributor.authorLópez Fornás, Francisco
dc.contributor.authorAriza Solé, Albert
dc.contributor.authorRaposerias, Sergio
dc.contributor.authorVivas, David
dc.contributor.authorBlanco, Regina
dc.contributor.authorBompart Berroterán, Daznia
dc.contributor.authorCordero, Alberto
dc.contributor.authorNúñez, Julio
dc.contributor.authorFácila, Lorenzo
dc.contributor.authorNúñez Gil, Iván
dc.contributor.authorGórriz, José Luis
dc.contributor.authorBodi, Vicente
dc.contributor.authorMartínez Selles, Manuel
dc.contributor.authorRuiz Nodar, Juan Miguel
dc.contributor.authorChorro, Francisco Javier
dc.date.accessioned2022-06-27T11:01:55Z
dc.date.available2022-06-27T11:01:55Z
dc.date.issued2022-05-26
dc.date.updated2022-06-27T10:00:12Z
dc.description.abstractThe treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also present coronary artery disease (CAD). It is imperative to deepen our knowledge regarding the management of these challenging patients through real-world data and specifically designed geriatric studies to help resolve the questions remaining in their disease management.
dc.format.extent15 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2077-0383
dc.identifier.pmid35683397
dc.identifier.urihttps://hdl.handle.net/2445/187068
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/jcm11113008
dc.relation.ispartofJournal of Clinical Medicine, 2022, vol. 11, num. 11
dc.relation.urihttps://doi.org/10.3390/jcm11113008
dc.rightscc by (c) Bonanad, Clara et al, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationMalalties del cor
dc.subject.classificationAnticoagulants (Medicina)
dc.subject.otherHeart diseases
dc.subject.otherAnticoagulants (Medicine)
dc.titleAntithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
jcm-11-03008.pdf
Mida:
331.09 KB
Format:
Adobe Portable Document Format